Body Composition and Hormonal Status in Ataxia Telangiectasia

Study Overview
=================
Brief Summary
-----------------
Ataxia telangiectasia (A-T) is a rare devastating human recessive disorder characterized by progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and cancer susceptibility. In addition to that, a high percentage of patients show dystrophy, growth retardation and poor weight gain. Nevertheless, there are only a few studies assessing this problem. Aim of the present proposal is to investigate the exact body composition, manual muscle strength and hormonal status in patients with A-T compared to healthy controls matched for gender and age. A pelvic sonography in females was performed in order to evaluate the sexual maturity of their inner genitalia. Tanner score was determined to define the physical development. Every subject received a nutritional diary to review its calorie intake and the quality of diet. The investigators expect that the A-T cohort shows an altered body composition, impaired muscle strength, changed hormonal status concerning the sexual hormones and a delayed physical development compared to healthy controls.

Detailed Description
-----------------
Ataxia telangiectasia (A-T) is a devastating human recessive disorder characterized by progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and cancer susceptibility. In addition to that, a high percentage of patients show dystrophy, growth retardation and poor weight gain. There are only a few studies assessing this problem and the exact variations concerning body composition, muscle strength and hormonal status are widely unknown. Major factors may be responsible for altered body composition: Immunodeficiency and chronic disease are important influences on growth and physical development. The constantly catabolic situation of A-T patients has a major impact on dystrophy. Due to the progressive cerebellar ataxia most of the patients are bound to wheelchair so that their muscle mass is decreased Impaired muscle strength is related to apraxia, dystonia, contractures and dyskinesia. Low levels of growth hormones (GH). Extracerebellar MRI - lesions in A-T go along with deficiency of the GH axis thus causing nanism. Delayed puberty and physical development suggest an abnormal metabolism in muscle cells There are autopsy reports informing about reduced mass of the adrenal cortex that may be reflected in a lower hormone release of steroid hormones. The aim of the proposal is to explore the exact body composition, the manual muscle strength, the hormonal status in patients with A-T compared to healthy subjects matched for sex and age. One study visit is performed in all A-T patients and healthy subjects: To evaluate weight and length of all subjects To analyze the exact structure of single body compartments such as the lean mass, the water compartment or the fat compartment using bioelectrical impedance analysis To determine the subcutaneous fat fold thickness using calipometry To investigate the nourishment habits and diet detected by nutritional diary To analyze the manual muscle strength with a hand dynamometer To determine the physical development in the A-T cohort by Tanner scores To evaluate stage of sexual development and puberty in female A-T patients by ultrasonic of the inner genitalia To get a detailed hormonal status including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), GH, cortisol, DHEAS, estradiol, testosterone, progesterone, insulin like growth factor-binding protein 3 (IGF-BP3), etc in serum blood

Official Title
-----------------
Body Composition, Muscle Strength and Hormonal Status in Patients With Ataxia Telangiectasia Compared to Healthy Controls

Conditions
-----------------
Ataxia Telangiectasia

Intervention / Treatment
-----------------
* Procedure: bioelectrical impedance analysis
* Procedure: blood draw


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: aim group: clinically and/or genetically diagnosed A-T control group: age and sex matched healthy subjects age 2-45 years written informed consent Exclusion Criteria: age < 2 or > 45 years other diseases with influence on the immunosystem (i.e. diabetes mellitus, malignoma, dialysis-dependent renal failure) current medication with hormones

Ages Eligible for Study
-----------------
Minimum Age: 2 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Ataxia telangiectasia<br>26 patients with clinically and/or genetically diagnosed Ataxia telangiectasia will be examined with bioelectrical impedance analysis (BIA), muscle force measurement, calipometry and get a blood draw | Procedure: bioelectrical impedance analysis<br>* electrophysical measurement that allows to determine the exact composition of single body compartments by producing a magnetic field and detecting the potential difference through the body<br>Procedure: blood draw<br>* blood samples are taken at 8 am in order to pay attention to the circadian rhythmicity to get a detailed hormonal status<br>|
| Active Comparator: Healthy subjects<br>26 age and sex matched subjects without any chronic disease or hormone displacement will be examined with bioelectrical impedance analysis (BIA), muscle force measurement, calipometry and get a blood draw | Procedure: bioelectrical impedance analysis<br>* electrophysical measurement that allows to determine the exact composition of single body compartments by producing a magnetic field and detecting the potential difference through the body<br>Procedure: blood draw<br>* blood samples are taken at 8 am in order to pay attention to the circadian rhythmicity to get a detailed hormonal status<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Body mass index |  | 12 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
dystrophy, body composition, malnutrition